Երկիր: Միացյալ Թագավորություն
Լեզու: անգլերեն
Աղբյուրը: VMD (Veterinary Medicines Directorate)
Iron
Ceva Animal Health Ltd
QBO3AC
Iron
Solution for injection
POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person
Pigs
Mineral antianaemia
Authorized
1995-08-30
Revised: October 2022 AN: 01664/2022 Page 1 of 4 SUMMARY OF PRODUCTS CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Gleptosil 200mg/ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Iron (as gleptoferron complex). EXCIPIENTS: Phenol For the full list of excipients see Section 6.1 200 mg/ml 498 mg/ml) 5 mg/ml 3. PHARMACEUTICAL FORM Solution for injection. A dark brown, slightly viscous, sterile, colloidal, aqueous solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Neonatal pigs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Neonatal pigs: For the prevention and treatment of iron deficiency anaemia. 4.3 CONTRAINDICATIONS None 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None 4.5 SPECIAL PRECAUTIONS FOR USE i) Special precautions for use in animals Normal aseptic injection techniques should be practised. ii) Special precautions for the person administering the veterinary medicinal product to animals Revised: October 2022 AN: 01664/2022 Page 2 of 4 Care should be taken to avoid accidental self injection. In the event of accidental self injection seek medical advice. Wash hands after use. iii) Other precautions The sachet should not be opened until the product is required for use. Avoid the introduction of contamination during use. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) There are normally no undesirable side effects associated with the use of the product. Its use does not result in permanent staining of the injected muscle tissue. 4.7 USE DURING PREGNANCY, LACTATION OR LAY Not applicable 4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION There are no known interactions between the product and other medicaments. There are no known other forms of interaction. Do not mix with other products prior to administration. 4.9 AMOUNT TO BE ADMINISTERED AND ADMINISTRATION ROUTE Use only automatic syringe equipment Swab the septum before use. The product is administered as a single 1 mL (200 mg iron) dose by deep intramuscular injectio Կարդացեք ամբողջական փաստաթուղթը